David Ford
Human Resources Officer bei PROTHENA CORPORATION PLC
Profil
David Ford is currently the Director at Lightpoint Medical Ltd.
and the Chief People Officer at Prothena Corp.
Plc.
Previously, he held positions as the Director of Human Resources at Sanofi-Synthélabo Ltd.
and Sanofi-Synthélabo Ireland Ltd.
He also served as the Vice President of Human Resources at Genzyme Corp.
and Sanofi US Services, Inc. Additionally, he was the Chief Human Resources Officer at Intercept Pharmaceuticals, Inc. Mr. Ford obtained an MBA from INSEAD.
Aktive Positionen von David Ford
| Unternehmen | Position | Beginn |
|---|---|---|
| PROTHENA CORPORATION PLC | Human Resources Officer | 04.03.2024 |
Lightpoint Medical Ltd.
 Lightpoint Medical Ltd. Medical SpecialtiesHealth Technology Lightpoint Medical Ltd. develops imaging technology for cancer surgery. It has developed a groundbreaking surgical imaging technology based on Cerenkov Luminescence Imaging(CLI). The firm's CLI has the potential to detect cancer in real-time during surgery, and thereby reduce the need for repeat operations. The company was founded by David Tuch in 2012 and is headquartered in Chesham, the United Kingdom. | Director/Board Member | - |
Ehemalige bekannte Positionen von David Ford
| Unternehmen | Position | Ende |
|---|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Human Resources Officer | 01.12.2023 |
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Human Resources Officer | 01.05.2017 |
Sanofi US Services, Inc.
 Sanofi US Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi US Services, Inc. engages in the research, production and distribution of pharmaceutical products. The private company is based in Bridgewater, NJ. | Human Resources Officer | 01.12.2015 |
| Sanofi-Synthélabo Ireland Ltd. | Human Resources Officer | - |
Sanofi-Synthélabo Ltd.
 Sanofi-Synthélabo Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products. | Human Resources Officer | - |
Ausbildung von David Ford
| INSEAD | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| INTERCEPT PHARMACEUTICALS, INC. | Health Technology |
| PROTHENA CORPORATION PLC | Health Technology |
| Private Unternehmen | 5 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi-Synthélabo Ltd.
Sanofi-Synthélabo Ltd. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi-Synthélabo Ltd. is a pharmaceutical company based in Reading, UK. The British company was founded in 1990 and specializes in manufacturing and distributing solid-dose and pharmaceutical products. | Health Technology |
Sanofi US Services, Inc.
Sanofi US Services, Inc. Pharmaceuticals: MajorHealth Technology Part of Sanofi, Sanofi US Services, Inc. engages in the research, production and distribution of pharmaceutical products. The private company is based in Bridgewater, NJ. | Health Technology |
Lightpoint Medical Ltd.
Lightpoint Medical Ltd. Medical SpecialtiesHealth Technology Lightpoint Medical Ltd. develops imaging technology for cancer surgery. It has developed a groundbreaking surgical imaging technology based on Cerenkov Luminescence Imaging(CLI). The firm's CLI has the potential to detect cancer in real-time during surgery, and thereby reduce the need for repeat operations. The company was founded by David Tuch in 2012 and is headquartered in Chesham, the United Kingdom. | Health Technology |
| Sanofi-Synthélabo Ireland Ltd. |
